Industry Insights
Two leading US academic medical centres independently surveyed the commercial market and concluded none of the off-the-shelf molecular pathology software fit. Here is the evidence-based framework — six criteria, five red flags, seven vendor questions — for choosing a system that actually works.
Read blog post